Research

Advancing Medical Microbiology Through Scientific Research and Innovation

Scientific research is a fundamental component of Dr. Marwa Elaraby’s academic career. Her work focuses on improving diagnostic accuracy, advancing laboratory medicine, and supporting evidence-based clinical practice through high-quality research in Medical Microbiology and Immunology.

Her research integrates clinical microbiology, molecular diagnostics, immunology, and translational laboratory medicine, with the goal of translating scientific discoveries into practical diagnostic applications that improve patient care and healthcare outcomes.

Dr. Elaraby remains committed to scientific integrity, interdisciplinary collaboration, and innovation while contributing to the continued advancement of laboratory medicine and infectious disease research.

Research Interests

Dr. Elaraby’s research focuses on clinically relevant questions in diagnostic microbiology, laboratory medicine, and molecular diagnostics.

Areas of Research Interest

  • Diagnostic Medical Microbiology

  • Clinical Microbiology

  • Medical Immunology

  • Molecular Diagnostics

  • Diagnostic Biomarkers

  • Sepsis and Inflammatory Biomarkers

  • Infectious Diseases

  • Antimicrobial Resistance

  • Blood Culture Diagnostics

  • Clinical Laboratory Medicine

  • Translational Microbiology Research

  • Infection Prevention and Control

Current Research Projects

Dr. Elaraby is actively involved in research projects that explore emerging diagnostic technologies, novel biomarkers, antimicrobial resistance, and laboratory methods with potential clinical applications.

Evaluation of Zinc Oxide Nanoparticles Against Clinical Isolates of Proteus mirabilis from Urinary Tract Infections

Investigating the antimicrobial activity of zinc oxide nanoparticles against clinical bacterial isolates to explore alternative therapeutic strategies for antimicrobial-resistant urinary tract infections.

Evaluation of Circular RNA ZFR and Soluble CD155 as Novel Biomarkers for Hepatocellular Carcinoma

Assessing emerging molecular biomarkers that may improve the diagnosis and clinical evaluation of hepatocellular carcinoma through advanced molecular diagnostic techniques.

Correlation Between Pediatric Blood Culture Volume, Detection Rate, and Time to Positivity

Evaluating the relationship between blood culture specimen volume and microbiological diagnostic performance to optimize the diagnosis of pediatric bloodstream infections.

Selected Publications

Evaluation of Ascitic Fluid Calprotectin as an Accurate Marker for Rapid Diagnosis of Spontaneous Bacterial Peritonitis in Patients with Chronic Liver Disease

Egyptian Journal of Medical Microbiology

Volume 31, Issue 1 (2022)

This study evaluated ascitic fluid calprotectin as a rapid diagnostic biomarker for spontaneous bacterial peritonitis in patients with chronic liver disease, demonstrating its potential role in improving early diagnosis and clinical decision-making.

Study of MicroRNA-146a Expression and Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Serum Levels in Patients with Sepsis

Egyptian Journal of Medical Microbiology

Volume 35, Issue 2 (2026)

This research investigated the diagnostic value of MicroRNA-146a and soluble TREM-1 as biomarkers for sepsis and systemic inflammatory responses, supporting their potential application in early diagnosis and disease assessment.

Research Profiles

Dr. Elaraby maintains professional academic profiles that provide access to her publications, institutional affiliations, and scholarly activities.

Academic Profiles

  • Google Scholar

  • ORCID

  • Benha University Faculty Profile

(Display professional profile cards below, each linked directly to the corresponding profile.)

Research Collaboration

Dr. Elaraby welcomes opportunities for interdisciplinary collaboration in Medical Microbiology, Immunology, and Laboratory Medicine. She is interested in collaborative research projects, multicenter studies, scientific publications, academic partnerships, and educational initiatives that advance laboratory medicine and improve healthcare outcomes.

Potential areas of collaboration include:

  • Diagnostic microbiology

  • Molecular diagnostics

  • Infectious diseases

  • Laboratory medicine

  • Antimicrobial resistance

  • Biomarker research

  • Infection prevention and control

  • Medical education

  • Translational laboratory research

Researchers, academic institutions, healthcare organizations, and industry partners interested in collaborative opportunities are welcome to connect through the Contact page.

Research Philosophy

Dr. Elaraby believes that scientific research is essential for advancing laboratory medicine and improving patient care. By integrating microbiology, immunology, molecular diagnostics, and clinical practice, her work seeks to transform scientific evidence into meaningful diagnostic solutions that support healthcare professionals and benefit patients.

Her research is guided by scientific integrity, innovation, collaboration, and a commitment to evidence-based medicine, with the overarching goal of contributing to the continued advancement of Medical Microbiology and Immunology.